Objectives To describe the allometric scaling principles underlying appropriate indexing of cardiovascular and respiratory measurements obtained in adult mammals, and to propose guidelines for indexing experimental cardiovascular and respiratory data.
Introduction
Numerous variables of interest to the anesthesiologist are known to vary as a function of body size. Many variables increase as body size increases (e.g. cardiac output, minute ventilation), whereas others decrease as body size increases (e.g. heart rate, respiratory rate) and some do not vary systematically with body size (e.g. blood pressure, hematocrit). Many researchers have recognized the utility of expressing cardiopulmonary variables known to vary with body size as values indexed to another size-related variable; for example, cardiac index may be calculated as the quotient of cardiac output and body surface area (BSA). Such expressions reduce the variability of measurements, may artificially eliminate the effect of body size on the variable and give a clearer indication of how an individual animal's values compare with those expected for a typical animal of its body size. However, a variety of methods for such indexing are found in the literature. The simplest, and possibly most common adjustment, is to divide the measurement by body mass and present it mass-specifically. Although this is appropriate for some variables, as will be described, many cardiopulmonary variables increase or decrease in a manner that is not directly proportional to body mass, and indexing them to body mass will under-or overestimate, respectively, the true size-adjusted value; this error will be amplified as body size difference (Table 1) . Therefore, the actual function of body mass with which the variable changes should be used for indexing. Examining the veterinary anesthesia literature confirms that incorrect indexing of cardiopulmonary measurements is common; for example, of 10 articles recently published in this journal that reported both cardiac index and stroke index, four used methods of indexing unsupported by allometric principles. In addition, in these four manuscripts, cardiac output and stroke volume were incorrectly indexed using the same function of body mass, which suggests that heart rate is not expected to be affected by body size (see below), a supposition known to be incorrect.
Scaling describes the structural and functional consequences of changes in size or scale among otherwise similar organisms (Schmidt-Nielsen 1984) . Allometric scaling refers to the scaling of bodies or functions that do not vary in direct proportion to their size (Schmidt-Nielsen 1984) . , where Y 0 is a constant, characteristic of the type of organism and equal to the value of the variable of interest in a 1 kg (assuming that M is expressed in kg) animal, b is the allometric exponent, and M is body mass (West et al. 1997 ).
The value of b usually ranges from − 1 to 1 for cardiopulmonary variables; negative values indicate that the variable decreases as body size increases, and positive values indicate that the variable increases as body size increases. When the exponent is 0, the variable is 'sizeindependent': it does not vary as a function of body size (see below). A simplified interpretation of the effects of different exponents in allometric equations is to consider the magnitude of the effect of changes in size, based on the logarithms of the exponent. (West et al. 1997; Dodds et al. 2001; Glazier 2005 Glazier , 2010 (Kleiber 1932) . It should be noted that in the allometry literature, mass exponents derived from empirical data are typically expressed as decimal values (e.g. 0.74), whereas those denoting a generalized underlying relationship are expressed as fractions (e.g. 3/4). A few years later, studies using an even larger range of body sizes (mouse to elephant) reported similar findings (Brody et al. 1934; Benedict 1938) . Kleiber (1975) noted that these empirical allometric exponents were not significantly different from 0.75, and M 3/4 has become the most common scaling exponent relating body size to metabolism for interspecific comparisons.
Cardiopulmonary variables scaling this way include cardiac output, minute ventilation and oxygen consumption.
Several authors have pointed out that Kleiber's 'law' is an empirical approximation rather than a law, and that the 3/4 exponent is likely not to be universally applicable (Hayssen & Lacy 1985;  Kolokotrones et al. 2010; Hulbert 2014; White & Kearney 2014) . Nevertheless, data analysis of the basal metabolic rate of adult mammals often yields the 3/4 exponent (or exponents that are not statistically different from 3/4), although some authors have suggested that the 'true' exponent is closer to 2/3, and that 3/4 is probably related to contamination of the dataset with non-basal measurements (White & Seymour 2003 , 2005 Glazier 2005 ).
Interspecific and intraspecific size effects
Kleiber's law was empirically derived by collecting data from a variety of species, including both mammals and birds. His conclusion has been criticized based on the fact that, within a species, the effect of size on metabolism and cardiopulmonary variables appears to be best
, as originally reported by Rubner (1883) and later reinforced by Heusner (1982) . It has since been argued that scaling within a species (intraspecific) appears to more closely fit a mass exponent of 2/3, whereas scaling between species (interspecific) seems to better fit a mass exponent of 3/4; there are experimental and theoretical justifications for the use of both allometric exponents (Feldman & McMahon 1983) . Similarly to the 3/4 exponent, it has been suggested that the 2/3 exponent does not apply in all contexts and that the exponents may take a variety of values depending on the measurement being made (Glazier 2005) . Table 2 . Some additional relationships can be hypothesized based on the variables for which there are experimental data. For example, arterial oxygen concentration is considered not to vary with body size (West & Brown 2005) , which implies that oxygen delivery should vary as a function of body mass similarly to cardiac output. (Table 3) . Variables with a mass exponent of 0 are expected to be size-independent and thus not to vary with body size. Examples of such variables include hematocrit or hemoglobin concentration, and arterial oxygen tension (PaO 2 ) and carbon dioxide tension (PaCO 2 ). Blood pressure has typically been considered to be size-independent, although a recent study challenges this assumption (White & Seymour 2014) . Although the PaO 2 required for 50% hemoglobin saturation (P 50 ) scales in mammals with a negative mass exponent (Schmidt-Nielsen & Larimer 1958) , at sea level at rest, hemoglobin is close to being fully saturated with oxygen at normal PaO 2 in healthy mammals. Because the two determinants of arterial oxygen concentration are hemoglobin concentration and PaO 2 , both of which are considered to be size-independent, arterial oxygen concentration is also expected to be size-independent. Variables with a mass exponent of 1 change in direct proportion to body mass. Such variables include blood volume, heart mass, stroke volume, lung volume and tidal volume. The mass exponent for the majority of the remaining variables is 3/4 interspecifically (2/3 intraspecifically) and applies to variables such as oxygen consumption, cardiac output and minute ventilation that increase with body size, but not in direct proportion to it. Most biological frequencies, such as heart rate or respiratory rate, scale with a mass exponent of − 1/4 (or − 0.25), which indicates that they are lower in larger animals. Circulation time scales with an exponent of 1/4 as it is derived from the ratio of blood volume (exponent: 1) and cardiac output (exponent: 3/4). Similarly, vascular resistance, which is related to the ratio of pressure (exponent: 0) and cardiac output (exponent: 3/4), is expected to 
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Implications for indexing experimental cardiovascular and respiratory data
The literature on allometric scaling describes the relationships between body size and most common cardiovascular and respiratory variables. This information should be used when interpreting cardiopulmonary data with consideration of the effect of body size. As Table 1 shows, indexing these variables to an incorrect function of body mass would result in an incomplete and inaccurate interpretation. It should also be noted that if body size were fairly homogeneous in the sample being studied, there would be no effect on the variability of the measurements whether one applied the appropriate function of body mass, an inappropriate function of body mass, or used the raw measurements. If all subjects in the sample have similar body mass, correcting for body mass or any function of body mass will be equivalent to dividing the measurements by a constant, which does not affect their relative variability. Nevertheless, in this situation, the only logical approaches are either to not correct for body size or to correct for the appropriate function of body size, and the latter may allow better comparisons with other published data.
Exponents for indexing cardiovascular and respiratory data are reported in Table 3 , and exponents for a few additional variables are described in the text above. It should be noted that these exponents are for comparisons between species such as when data are obtained in multiple species, or if the goal for correcting the raw data for body size is to allow for the making of interspecies comparisons or estimates. Because the literature suggests that the slope for metabolic rate, and therefore probably many of the cardiovascular and respiratory variables, is lower when individuals of a single species are examined (Heusner 1982 1983; Schmidt-Nielsen 1984), it may be appropriate to modify the exponents in Table 3 for comparisons and correction of data within a species. In this case, the 3/4 and − 3/4 exponents would become 2/3 and − 2/3, respectively, and the 1/4 and − 1/4 exponents would become 1/3 and − 1/3, respectively. The existence of two different sets of exponents describing the effect of size within and between species may be related to similarities in body shape among animals of the same species, compared with systematic changes in dimensions dictated by size in animals of different species. Previous authors have suggested that, within a species, geometric similarity underlies the effect of body size, whereas elastic similarity may be more important between animal species (Feldman & McMahon 1983) . , as does intraspecific metabolic rate, it is often used to index cardiopulmonary data for comparisons within a species. As we have discussed, and as Table 3 shows, this is only appropriate for variables that vary in proportion to intraspecific metabolic rate. In addition, one of the arguments cited as supporting the indexing of cardiopulmonary measurements mass-specifically (to M) rather than to BSA, even for variables known to vary as and hence the relationship between M and BSA has the same exponent (slope of a log-log allometric plot) as cardiovascular and respiratory variables that vary with intraspecific metabolic rate. Because only the exponent is relevant for indexing, dividing the measurement by a BSA that can be read off a chart may be pragmatic, but it is simpler, and arguably more correct, to simply divide these measurements by M It should be noted that because there is some uncertainty regarding the actual values of the allometric exponents, and because the values of the exponents may vary with the conditions under study, analysis of covariance may be a preferable approach to traditional indexing to account for the effect of body size on cardiopulmonary measurements (Packard & Boardman 1988 , 1999 . This approach has been utilized to account for the degree of interrelatedness between species in the development of phylogenetically informed allometry (Garland et al. 2005 ).
In conclusion, we suggest that when cardiovascular and respiratory variables are indexed to account for the effect of body size, this indexing should: 1) use body mass raised to the appropriate exponent according to the allometric scaling literature; 2) use different exponents for inter-versus intraspecific comparisons; and 3) ensure that variables which scale intraspecifically with metabolic rate (M 
